Ειδήσεις: DRUG_DEVELOPMENT | PXAI

27/04 17:51 statnews.com

STAT+: An insider reveals the real goals of prior authorization

DRUG DEVELOPMENT POLICY STAT+INSURANCE PATIENTS LEGAL

27/04 16:20 statnews.com

STAT+: Astellas retries XLMTM gene therapy after deaths

BIOTECHNOLOGY PHARMA RESEARCH BUSINESS DRUG DEVELOPMENT POLITICS

27/04 14:01 statnews.com

STAT+: Intellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trial

DRUG DEVELOPMENT GENE EDITING RARE DISEASES PHARMA BIOTECH POLITICS

27/04 14:00 statnews.com

STAT+: Oruka’s long-acting psoriasis therapy posts strong results in mid-stage study

DRUG DEVELOPMENT BIOTECHNOLOGY CHRONIC DISEASES STAT+PHARMACEUTICALS BIOTECH

27/04 11:30 statnews.com

Opinion: I’m a fourth-year med student, but I only learned one historical example of medical racism

CDC PUBLIC HEALTH ECONOMY DRUG DEVELOPMENT FIRST OPINION POLITICS

25/04 14:00 statnews.com

Opinion: The podcast telling the stories behind Ambien, Ozempic, EpiPens, and other game-changing drugs

POLITICS FIRST OPINION PODCAST FIRST OPINION PHARMACEUTICALS DRUG DEVELOPMENT PUBLIC HEALTH

24/04 21:45 statnews.com

STAT+: FDA to speed up review of 3 psychedelics as mental health treatments

FDA PHARMA RESEARCH STAT+BIOTECHNOLOGY DRUG DEVELOPMENT

24/04 16:19 statnews.com

STAT+: Sanofi MS drug gets positive review in Europe following FDA

DRUG DEVELOPMENT THE READOUT POLITICS DRUG PRICING RESEARCH PHARMACEUTICALS

22/04 17:40 statnews.com

STAT+: The latest biotech news: RevMed, Roche, Kyverna CAR-T therapy

THE READOUT DRUG DEVELOPMENT BIOTECH PHARMA RESEARCH POLITICS

22/04 17:40 statnews.com

STAT+: The latest biotech news: RevMed, Roche, Kyverna CAR-T therapy

THE READOUT DRUG DEVELOPMENT BIOTECH PHARMA RESEARCH POLITICS

Loading...